OPTIMIZATION OF CARDIOGENIC SHOCK TREATMENT
Keywords:
acute myocardial infarction, acute heart failure, vasopressor therapyAbstract
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death and disability worldwide, with ST-segment elevation myocardial infarction (STEMI) leading [6]. Despite such advances and the widespread introduction into clinical practice of many effective drugs, angioplasty and surgical treatment, CHD kills 17.3 million people annually, which is 30% of all deaths worldwide [7,10]. Scientific significance: in acute myocardial infarction with blinded cardiogenic shock (class IV acute heart failure) norepinephrine is reasonable. Norepinephrine does not cause proarrhythmic actions, shortens bed days and is more economically significant than other vasopressors.
References
Akhmedov L.A., Poulatova Sh.H. Optimization of hemodynamic diagnostics of acute left ventricular failure // Materials of the 7th Eurasian Congress of Cardiology. In J. Cardiology of Uzbekistan. 2019, С. 255.
Kenjaev ML, Ahmedov LA, Povlatova SH, Boboeva MM The course of myocardial infarction in patients of young age // Bulletin of Physicians. Tashkent, 2017.- No.4 - P.44.
Kenjaev ML, Ahmedov LA, Pulatova SH, Boboeva MM. Cardiogenic shock bilan asoratlangan útkir myocardial infarcti davosida vasopressor therapy takomillashtirish // Bulletin of therapists. Tashkent, 2017.- No.1 - P.31
Pulatova, Sh. H. (2012). Founders: Institute of Immunology of the Academy of Sciences of the Republic of Uzbekistan. THEORETICAL AND CLINICAL MEDICINE
Pulatova, Sh. H. (2012). Founders: Institute of Immunology, Academy of Sciences of the Republic of Uzbekistan. THEORETICAL AND CLINICAL MEDICINE Founders: Institute of Immunology, Academy of Sciences of the Republic of Uzbekistan ISSN: 2091-5853
Khamroev, E. E., Nurboev, F. E., & Pulatova, S. K. (2022). CHRONIC HEART FAILURE: FEATURES CLINICAL MANIFESTATIONS IN THE ELDERLY. British Medical Journal, 2(2).
Pulatova Sh.H. Method of improving vasopressor therapy for acute myocardial infarction complied with cardiogenetic shock // American Journal Of Medicine And Medical Sciences. 2020.– Vol. 10 (11). – – Р. 911-913
Pulatova Sh.H. Improvement of treatment of patients with acute heart failure, a comparative evaluation of the effectiveness of dobutamine and levosimendan// World Journal Of Pharmaceutical Research. 2020. Vol 9 (6). –P. 2283-2288
Khamroev, E. E., F. E. Nurboev, and Sh Kh Pulatova. "CHRONIC HEART FAILURE: FEATURES CLINICAL MANIFESTATIONS IN THE ELDERLY." British Medical Journal 2, no. 2 (2022).
Турдиев, У. М. "UNSTABLE PROGRESSIVE ANGINA." УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ 3.3 (2022).
